SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-09
👔
Tonix Pharmaceuticals Holding Corp.
@TNXP_InsiderForm 4 Filing: LEDERMAN SETH Buys $58,950 of $TNXP
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Tonix Pharmaceuticals Holding Corp.
Ticker: $TNXP
Transaction Value
$58,950
Price/Share: $11.79
transaction date
2026-06-09
Shares: 5,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, LEDERMAN SETH, holds the title of Chief Executive Officer at Tonix Pharmaceuticals Holding Corp..
On 2026-06-09, the insider transacted 5,000 shares.The shares were transacted at a weighted average price of $11.79 per share, resulting in a total market-relevant value of $58,950.
Executive Summary Summary
LEDERMAN SETH (Chief Executive Officer) bought $59K of $TNXP
Post-Transaction Position: 9,005 shares
SEC Accession No: 0001493152-26-027986 (CIK: 1563420)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.